Biblio
Hematopoiesis Revolves Around the Primordial Evolutional Rhythm of Purinergic Signaling and Innate Immunity - A Journey to the Developmental Roots. Stem Cell Rev Rep. 2024.
. . . .
External Liver-Derived Complement and Intrinsic Present in Hematopoietic Stem/Progenitor Cells Complosome Modulate Cell Metabolism and Response to Stress. Stem Cell Rev Rep. 2023.
. Hematopoietic stem cells on the crossroad between purinergic signaling and innate immunity. Purinergic Signal. 2023.
. . Intracellular Complement (Complosome) is Expressed in Several Types of Human Adult Bone Marrow-Derived Stem Cells. Stem Cell Rev Rep. 2023.
. Mesenchymal Stem Cell-Macrophage Crosstalk Provides Specific Exosomal Cargo to Direct Immune Response Licensing of Macrophages during Inflammatory Responses. Stem Cell Rev Rep. 2023.
. Molecular analysis and comparison of CD34 and CD133 very small embryonic-like stem cells (VSELs) purified from umbilical cord blood (UCB). Cytometry A. 2023.
. The "Mystery Cell Population" Residing in Murine Bone Marrow - A Missing Link Between Very Small Embryonic Like Stem Cells and Hematopoietic Stem Cells?. Stem Cell Rev Rep. 2023.
. Pineal Gland Hormone Melatonin Inhibits Migration of Hematopoietic Stem/Progenitor Cells (HSPCs) by Downregulating Nlrp3 Inflammasome and Upregulating Heme Oxygenase-1 (HO-1) Activity. Stem Cell Rev Rep. 2023.
. Stem Cell Reviews and Reports - New Developments for 2024. Stem Cell Rev Rep. 2023.
. . .
August Issue of Stem Cell Reviews and Reports Including a Spotlight Paper from Dr. Hal Broxmeyer on a Role of Brain in Regulating Hematopoiesis. Stem Cell Rev Rep. 2021.
. December Issue of Stem Cell Reviews and Reports Highlights Future Directions in the Mobilization of Hematopoietic Stem Cells and Presents Clinical Results of the First CAR-T Cell Treatment for Systemic Lupus Erythromatosus. Stem Cell Rev Rep. 2021.
. The Nlrp3 inflammasome - the evolving story of its positive and negative effects on hematopoiesis. Curr Opin Hematol. 2021.
. . The Inhibition of CD39 and CD73 Cell Surface Ectonucleotidases by Small Molecular Inhibitors Enhances the Mobilization of Bone Marrow Residing Stem Cells by Decreasing the Extracellular Level of Adenosine. Stem Cell Rev Rep. 2019.
. . Very Small Embryonic-Like Stem Cells (VSELs). Circ Res. 2019;124(2):208-210.
. . .